Dr. Saad Usmani, MD

Claim this profile

Levine Cancer Institute

Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
4 reported clinical trials
9 drugs studied

Affiliated Hospitals

Image of trial facility.
Levine Cancer Institute

Clinical Trials Saad Usmani, MD is currently running

Image of trial facility.

Belantamab Mafodotin + SoC

for Multiple Myeloma

This study will evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of belantamab mafodotin in combination with Velcade (bortezomib), Revlimid (lenalidomide), dexamethasone (VRd) and will determine recommended phase 3 dose (RP3D) in adult participants with newly diagnosed multiple myeloma (NDMM). Participants will receive the combination of bortezomib, lenalidomide and dexamethasone (VRd) on a 3-week cycle until cycle 8, followed by the combination of lenalidomide and dexamethasone (Rd) on a 4-week cycle thereafter as per dosing schedule. Participants will receive belantamab mafodotin on a schedule that is dependent on the cohort to which they are assigned. Belantamab mafodotin will be administered in combination with VRd every 3 weeks (Q3W), every 6 weeks (Q6W), or every 9 weeks (Q9W) to Cycle 8, and then in combination with Rd every 4 weeks (Q4W), every 8 weeks (Q8W), or every 12 weeks (Q12W) thereafter. Participants will complete an End of Treatment (EOT) visit at the point of study treatment discontinuation, followed by a Safety Follow-up visit 70 days after EOT.
Recruiting1 award Phase 18 criteria

More about Saad Usmani, MD

Clinical Trial Related6 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Saad Usmani, MD has experience with
  • Lenalidomide
  • Dexamethasone
  • Bb2121
  • MMprofiler
  • Belantamab Mafodotin
  • Bortezomib
Breakdown of trials Saad Usmani, MD has run
Multiple Myeloma
Plasma Cell Neoplasms

Other Doctors you might be interested in

Shaker Dakhil, M.D.Ascension Via Christi Hospitals Wichita
Khalid MatinPeninsula Cancer Institute-Newport News
Isao SuzakiGSK Investigational Site

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Saad Usmani, MD specialize in?
Saad Usmani, MD focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Saad Usmani, MD currently recruiting for clinical trials?
Yes, Saad Usmani, MD is currently recruiting for 1 clinical trial in Charlotte North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Saad Usmani, MD has studied deeply?
Yes, Saad Usmani, MD has studied treatments such as Lenalidomide, Dexamethasone, bb2121.
What is the best way to schedule an appointment with Saad Usmani, MD?
Apply for one of the trials that Saad Usmani, MD is conducting.
What is the office address of Saad Usmani, MD?
The office of Saad Usmani, MD is located at: Levine Cancer Institute, Charlotte, North Carolina 28204 United States. This is the address for their practice at the Levine Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top